Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
alessia.dicostanzo@uniroma1.it
Alessia Di Costanzo
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
alessia.dicostanzo@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
JAMA CARDIOLOGY
2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries
EUROPEAN JOURNAL OF INTERNAL MEDICINE
2024
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
CURRENT ATHEROSCLEROSIS REPORTS
2023
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia.
LIVER INTERNATIONAL
2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study
LA RADIOLOGIA MEDICA
2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis
CIRCULATION
2023
ANGPTL3 Deficiency and Risk of Hepatic Steatosis
CIRCULATION
2023
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
THE LANCET
2022
Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease
BIOMEDICINES
2022
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway
BIOMOLECULES
2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content
ATHEROSCLEROSIS
2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study
FRONTIERS IN GENETICS
2022
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification
ATHEROSCLEROSIS
2022
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis
BIOCHIMICA AND BIOPHYSICA ACTA. MOLECULAR AND CELL BIOLOGY OF LIPIDS
2022
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2022
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2022
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
2022
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
2022
The interplay between angiopoietin-like proteins and adipose tissue: Another piece of the relationship between adiposopathy and cardiometabolic diseases?
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma